| __timestamp | Novavax, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 19928000 | 305409000 |
| Thursday, January 1, 2015 | 30842000 | 377080000 |
| Friday, January 1, 2016 | 46527000 | 432829000 |
| Sunday, January 1, 2017 | 34451000 | 496079000 |
| Monday, January 1, 2018 | 34409000 | 557616000 |
| Tuesday, January 1, 2019 | 34417000 | 658498000 |
| Wednesday, January 1, 2020 | 145290000 | 770456000 |
| Friday, January 1, 2021 | 298358000 | 840100000 |
| Saturday, January 1, 2022 | 488691000 | 944700000 |
| Sunday, January 1, 2023 | 468946000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, understanding financial trends is crucial. Over the past decade, Vertex Pharmaceuticals and Novavax have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vertex's SG&A expenses surged by approximately 270%, reflecting its aggressive expansion and market penetration strategies. In contrast, Novavax's expenses increased by nearly 2,250%, highlighting its rapid growth and scaling efforts, especially during the pandemic years.
By 2023, Vertex's SG&A expenses reached over 1.1 billion, a testament to its established market presence. Meanwhile, Novavax, with expenses nearing half a billion, underscores its emerging status in the biotech arena. This financial narrative not only showcases the companies' strategic priorities but also offers insights into their operational dynamics and market positioning.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Incyte Corporation
Vertex Pharmaceuticals Incorporated and Bio-Techne Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and MorphoSys AG
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs MannKind Corporation
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Incyte Corporation and Novavax, Inc.
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Novavax, Inc.
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Xencor, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared